vials and syringes are ready for the injection
Profhilo

Content prepared by Direct Doctor Supply’s Editorial team.


Last Updated On October 9, 2026

Is Profhilo FDA-Approved?

May 21, 2025

Healthy human skin is naturally rich in collagen, elastin, and hyaluronic acid, which provide essential hydration, elasticity, and resilience. However, these vital components decline with age, leading to skin laxity, fine lines, and reduced firmness. Environmental factors like sun exposure and pollution further accelerate these changes, fueling demand for effective skin rejuvenation treatments.

Among these treatments, Profhilo stands out for its innovative formulation and unique focus on enhancing skin quality rather than simply adding volume like traditional fillers. While popular in many countries, Profhilo is not FDA-approved in the United States—a critical consideration for patients and providers regarding accessibility and regulatory oversight.

This article aims to determine whether Profhilo is FDA approved and explore the implications for those seeking safe, effective skin-enhancing options in the U.S. and beyond.

Key Takeaways

  • Profhilo is CE-marked and widely used in Europe, the Middle East, and Asia, but it is not FDA-approved and cannot be legally used or marketed in the United States.
  • U.S. medical professionals must avoid administering Profhilo until it receives FDA clearance, as doing so risks legal penalties and compromises patient safety.
  • Providers should clearly communicate Profhilo’s unapproved status to patients influenced by international marketing or social media trends.
  • Safe and effective FDA-approved alternatives in the U.S. include Skinvive by Juvéderm, Restylane Skinboosters, Radiesse, Sculptra Aesthetic, and Belotero Balance.
  • It is important for U.S. practitioners to stay updated on Profhilo’s regulatory progress through clinical trial databases, conferences, industry publications, and manufacturer updates.
  • Patient safety, legal compliance, and ethical practice must remain top priorities while awaiting potential future FDA approval.
IBSA PROFHILO BODYKIT 01
PROFHILO® BODY KIT

$ 359.00
Add To Cart
–+
PROFHILO HL 01
PROFHILO® H+L

$ 179.00
Add To Cart
–+

About: Trusted by over 2,000+ global clients since 2014, Direct Doctor Supply has become a leading supplier of cosmetic, skincare, and orthopedic products for medical and aesthetic professionals. Direct Doctor Supply offers a wide range of authentic brand-name products at competitive wholesale prices, sourced from around the world.

Current Approval and Usage of Profhilo

Profhilo is approved for use in multiple countries across Europe, the Middle East, and Asia. Its CE marking confirms compliance with stringent European standards for safety, health, and environmental protection. However, CE marking is not equivalent to U.S. FDA approval.

In regions where Profhilo is permitted, medical professionals legally offer treatments to enhance skin hydration, elasticity, and overall texture by injecting highly concentrated hyaluronic acid. Patients have reported favorable outcomes, including skin tightening and increased radiance, particularly in the face, neck, and décolletage.

2026 Study Update

A 2026 systematic review examined nine studies involving 278 participants and found that Profhilo and Profhilo Body were associated with improvements in skin hydration, elasticity, density, and laxity, as well as reductions in wrinkle severity and facial volume-loss measures. Photographic assessments also demonstrated improvements in skin tone, texture, and turgor. Reported adverse effects were generally mild and temporary, including bruising, edema, localized hematomas, and small bumps. These findings add to the clinical evidence surrounding Profhilo’s skin-rejuvenating effects, but they do not change its regulatory status in the United States. Clinical evidence of safety or efficacy should not be interpreted as FDA approval.[4]

Despite these positive international results, Profhilo lacks FDA approval, so it cannot be legally marketed or used in the United States. Patients and providers familiar with its benefits abroad should be cautious, as U.S. use is prohibited. Direct Doctor Supply brings professional-grade aesthetic and medical products to one convenient online destination, making it easier to buy Profhilo online from a trusted supplier.

Implications for U.S. Medical Professionals

U.S.-based healthcare practitioners must not administer Profhilo until the FDA officially clears it. Using non-FDA-approved products can expose clinics and practitioners to serious legal consequences, including penalties and potential loss of licensure. Furthermore, offering such treatments may jeopardize patient safety and harm the clinic’s professional reputation.

relaxed and ready

Practitioners should clearly communicate Profhilo’s unapproved FDA status to patients, particularly those influenced by international marketing or social media trends. Clinics must avoid importing or using Profhilo injections from unregulated sources, as this violates federal law.

Until official approval is granted, U.S. aesthetic practices must adhere to regulatory guidelines to ensure compliance and uphold high standards of patient care.

Alternative FDA-Approved Treatments

While Profhilo remains unavailable in the U.S., several FDA-approved options provide similar skin-rejuvenating benefits in terms of hydration, texture enhancement, and overall skin quality:

  • Skinvive by Juvéderm: A hyaluronic acid-based injectable approved to enhance skin smoothness and hydration. In the ongoing debate between Profhilo and Skinvive, only Skinvive is FDA-approved for use in the United States.
  • Restylane® Skinboosters: Offer hydration and mild plumping effects; certain variants are FDA-approved.
  • Radiesse®: A calcium hydroxylapatite-based filler that stimulates collagen production and improves skin texture.
  • Sculptra® Aesthetic: Stimulates collagen over time, effective for skin tightening and volume restoration.
  • Belotero Balance®: FDA-approved to treat moderate-to-severe lines and wrinkles, with a smooth finish.

Each treatment has undergone rigorous clinical testing and regulatory review, making it a reliable option for practitioners seeking practical, compliant skin rejuvenation therapies. The best product depends on the patient’s skin condition, aesthetic goals, and medical history, especially when choosing between Profhilo vs Skinvive.

Monitoring Regulatory Developments

For anyone asking, “Is Profhilo FDA approved?“, staying up to date on its regulatory status matters, especially for clinicians considering it for their practice. Since regulatory decisions can change as new evidence becomes available, it’s best to follow reliable sources for the latest information

scientists in lab
  • FDA Clinical Trials Database (ClinicalTrials.gov): Lists ongoing studies evaluating Profhilo’s safety and effectiveness in the U.S.
  • Medical Aesthetics Conferences: Often provide updates on product trials, regulatory shifts, and new treatment technologies.
  • Professional Newsletters and Journals: Subscribe to aesthetic medicine publications for timely updates.
  • Manufacturer Updates: Follow IBSA Derma, the maker of Profhilo, for press releases and updates on FDA submissions.
  • Networking with Peers: Staying in touch with industry peers can provide early information on anticipated regulatory changes.

By monitoring these sources, practitioners can stay prepared to integrate Profhilo injections into their practice once it receives FDA clearance, if and when that occurs.

Conclusion

If you’re wondering whether Profhilo is FDA approved, it is important to understand that Profhilo is not FDA-approved for use in the United States. Although it is widely used internationally, U.S. practitioners should follow applicable FDA regulations and use appropriately authorized alternatives for skin rejuvenation when necessary.

Prioritizing patient safety, legal compliance, and professional reputation remains paramount. Staying informed and proactive helps medical professionals maintain ethical practices and build long-term patient trust.

FAQs

1. What is Profhilo?

Profhilo is an injectable skin treatment containing high concentrations of hyaluronic acid, designed to hydrate and improve skin elasticity.

2. How is Profhilo different from dermal fillers?

Unlike fillers, Profhilo spreads under the skin to stimulate collagen and elastin without adding volume or structure.

3. Where is Profhilo commonly injected?

It is most often used on the face, neck, hands, and décolletage to improve skin tone, texture, and firmness.

4. Is Profhilo safe?

Profhilo has been deemed safe in countries where it is approved, but like all injectables, it can have side effects.

5. How many sessions are needed?

A typical Profhilo treatment involves two sessions spaced four weeks apart, with maintenance treatments recommended every 6-9 months.

6. Are the results from Profhilo permanent?

No, results are temporary and usually last around six months, depending on the individual’s metabolism and skin condition.

7. Can I get Profhilo in the U.S. if I travel abroad?

While patients can receive Profhilo treatments in countries where it is legal, they must ensure licensed professionals in those regions administer the treatments.

Need help, additional info, or customized deals?

Talk with our sales representative.

Book a Meeting

Citations

Kim, M. S., K. E. Chun, D. K. Lee, and S. H. Song. “Evaluation of the Efficacy of an Elastin-Inducing Composition Containing Amino Acids, Copper, and Hyaluronic Acid: Results of an Open Single-Center Clinical Trial Study.” Cosmetics, vol. 9, no. 3, 2022, p. 51. doi:https://doi.org/10.3390/cosmetics9030051 

FDA-Approved Dermal Fillers. Center for Devices and Radiological Health, U.S. Food and Drug Administration, 4 Nov. 2021.

What Is Skin Rejuvenation? Verywell Health. https://www.verywellhealth.com/skin-rejuvenation-5120583.

Sparavigna, A., C. Cigni, L. Tanzini, R. Lualdi, and F. Grimolizzi. “A Systematic Review of the Efficacy and Safety of Profhilo® and Profhilo® Body.” Plastic and Aesthetic Nursing, vol. 46, no. 2, 2026, pp. 80–92. doi:10.1097/psn.0000000000000637.

Sourcing and accuracy for this article follow our Editorial policy: claims are cross-checked against clinical literature, regulatory filings, and manufacturer specifications before anything is published